Literature DB >> 21956509

Objective, user-independent ELISPOT data analysis based on scientifically validated principles.

Wenji Zhang1, Paul V Lehmann.   

Abstract

ELISPOT results used to be evaluated visually which, however, is inevitably subjective, inaccurate, and cumbersome. Even when applying automated image analysis to this end, the results are highly variable if the counting parameters are set subjectively. Since objective, accurate, and reproducible measurements are fundamental to science, major efforts have been undertaken over the last decade at CTL to understand the scientific principles behind ELISPOT data and to develop "intelligent" image analysis algorithms based on these principles. Thus, a spot recognition and gating algorithm was developed to automatically recognize the signatures of defined cell populations, such as T cells, discerning them from irrelevant cell types and noise. In this way, the science of ELISPOT data analysis has been introduced, permitting exact frequency measurement against background. As ELISPOT assays become a gold standard for monitoring antigen-specific T-cell immunity in clinical trials, the need has surfaced to make ELISPOT data transparent, reproducible, and tamper-proof, complying with Good Laboratory Practice (GLP) and Code for Federal Regulations (CFR) Part 11 guidelines. Flow cytometry-based and other immune monitoring assay platforms face the same challenge. In this chapter, we provide an overview of how CTL's ImmunoSpot(®) platform for ELISPOT data analysis, management, and documentation meets these challenges.

Mesh:

Year:  2012        PMID: 21956509     DOI: 10.1007/978-1-61779-325-7_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood.

Authors:  Giulietta Saletti; Nicolas Çuburu; Jae Seung Yang; Ayan Dey; Cecil Czerkinsky
Journal:  Nat Protoc       Date:  2013-05-09       Impact factor: 13.491

2.  Comparison of Rapid Cytokine Immunoassays for Functional Immune Phenotyping.

Authors:  Anthony S Bonavia; Abigail Samuelsen; Zissis C Chroneos; Eric Scott Halstead
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting.

Authors:  Alexey Y Karulin; Kinga Karacsony; Wenji Zhang; Oleg S Targoni; Ioana Moldovan; Marcus Dittrich; Srividya Sundararaman; Paul V Lehmann
Journal:  Cells       Date:  2015-01-20       Impact factor: 6.600

4.  Normal Distribution of CD8+ T-Cell-Derived ELISPOT Counts within Replicates Justifies the Reliance on Parametric Statistics for Identifying Positive Responses.

Authors:  Alexey Y Karulin; Richard Caspell; Marcus Dittrich; Paul V Lehmann
Journal:  Cells       Date:  2015-03-02       Impact factor: 6.600

5.  ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells.

Authors:  Jodi Hanson; Srividya Sundararaman; Richard Caspell; Edith Karacsony; Alexey Y Karulin; Paul V Lehmann
Journal:  Cells       Date:  2015-01-29       Impact factor: 6.600

6.  Reagent Tracker Dyes Permit Quality Control for Verifying Plating Accuracy in ELISPOT Tests.

Authors:  Alexander Lehmann; Zoltan Megyesi; Anna Przybyla; Paul V Lehmann
Journal:  Cells       Date:  2018-01-03       Impact factor: 6.600

7.  Comprehensive Evaluation of the Expressed CD8+ T Cell Epitope Space Using High-Throughput Epitope Mapping.

Authors:  Paul V Lehmann; Maneewan Suwansaard; Ting Zhang; Diana R Roen; Greg A Kirchenbaum; Alexey Y Karulin; Alexander Lehmann; Pedro A Reche
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

8.  High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated Cytotoxicity.

Authors:  Anna Welter; Srividya Sundararaman; Ruliang Li; Ting Zhang; Alexey Y Karulin; Alexander Lehmann; Villian Naeem; Diana R Roen; Stefanie Kuerten; Paul V Lehmann
Journal:  Cells       Date:  2018-04-24       Impact factor: 6.600

9.  Delayed Activation Kinetics of Th2- and Th17 Cells Compared to Th1 Cells.

Authors:  Andrea Duechting; Anna Przybyla; Stefanie Kuerten; Paul V Lehmann
Journal:  Cells       Date:  2017-09-12       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.